Patents by Inventor Rui Liang

Rui Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220141268
    Abstract: An online meeting system begins the process of connecting a user to an online meeting when the user enters a prejoin dialog for choosing meeting settings, rather than waiting until the user chooses to actually join the meeting after entering settings. Starting the meeting connection process at this time allows a shorter perceived connection time to the meeting and thus reduces user frustration with the meeting system.
    Type: Application
    Filed: January 14, 2022
    Publication date: May 5, 2022
    Inventors: Nagaswapna BHAMIDIPATI, Xin HE, Milica JOVANOVIC, Artur Pawel KANIA, Namendra KUMAR, Rui LIANG, Yue LI, Joel Harodi MARQUEZ CATANO, Abhilash Chandrasekharan NAIR, Gaurav PANCHOLI, Jindrich PARUS, Martin PETRLA, Denis POSTU, Rama Krishan Prasad SATYA PRAKASH, Kensaku SUEDA, Balvinder Kaur THIND, Hao XU
  • Patent number: 11320167
    Abstract: Disclosed is a centralized control method for a VRV air conditioning system, includes a debugging terminal sending a first acquisition request to a cloud server on the basis of an identification code, the debugging terminal creating a project on the basis of system information, the debugging terminal uploading project information corresponding to the project to the cloud server, and the cloud server generates a delivery code corresponding to the project information, a centralized control device sending a second acquisition request to the cloud server on the basis of the delivery code, and the centralized control device loading the project corresponding to the delivery code on the basis of the project information, and activating same. Also disclosed in the present application are a centralized control system for a VRV air conditioning system and a computer readable storage medium.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: May 3, 2022
    Inventors: Jie Yan, Rui Liang, Qiang Li
  • Publication number: 20220065798
    Abstract: Optical fabrication monitor structures can be included in a design fabricated on a wafer from a mask or fabrication reticle. A first set of components can be formed in an initial fabrication cycle, where the first set includes functional components and monitor structures. A second set of components can be formed by subsequent fabrication processes that can potentially cause errors or damage to the first set of components. The monitor structures can be implemented during fabrication (e.g., in a cleanroom) to detect fabrication errors without pulling or scrapping the wafer.
    Type: Application
    Filed: August 28, 2020
    Publication date: March 3, 2022
    Inventors: Erik Johan Norberg, Rui Liang, Benjamin M. Curtin, Jared Bauters
  • Patent number: 11252206
    Abstract: An online meeting system begins the process of connecting a user to an online meeting when the user enters a prejoin dialog for choosing meeting settings, rather than waiting until the user chooses to actually join the meeting after entering settings. Starting the meeting connection process at this time allows a shorter perceived connection time to the meeting and thus reduces user frustration with the meeting system.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: February 15, 2022
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Nagaswapna Bhamidipati, Xin He, Milica Jovanović, Artur Pawel Kania, Namendra Kumar, Rui Liang, Yue Li, Joel Harodi Marquez Catano, Abhilash Chandrasekharan Nair, Gaurav Pancholi, Jindrich Parus, Martin Petrla, Denis Postu, Rama Krishan Prasad Satya Prakash, Kensaku Sueda, Balvinder Kaur Thind, Hao Xu
  • Publication number: 20210364183
    Abstract: Disclosed is a centralized control method for a VRV air conditioning system, includes a debugging terminal sending a first acquisition request to a cloud server on the basis of an identification code, the debugging terminal creating a project on the basis of system information, the debugging terminal uploading project information corresponding to the project to the cloud server, and the cloud server generates a delivery code corresponding to the project information, a centralized control device sending a second acquisition request to the cloud server on the basis of the delivery code, and the centralized control device loading the project corresponding to the delivery code on the basis of the project information, and activating same. Also disclosed in the present application are a centralized control system for a VRV air conditioning system and a computer readable storage medium.
    Type: Application
    Filed: April 18, 2019
    Publication date: November 25, 2021
    Inventors: Jie YAN, Rui LIANG, Qiang LI
  • Patent number: 11113455
    Abstract: A method and apparatus is described for rendering web pages by a wireless device in order to reduce an amount of data transmitted over-the-air to the wireless device. In one embodiment, a method is performed by a server, comprising receiving a markup language document from a web server via a network interface, the markup language document corresponding to a web page. Next, the markup language document is parsed into a number of blocks by a processor, each of the blocks comprising code representing original content of the web page. Then, the processor creates one or more replacement blocks, each of the replacement blocks corresponding to a respective one of the blocks, each of the replacement blocks comprising code representing substituted content of the web page. Some of the blocks and at least one of the replacement blocks are then sent to a wireless device for rendering.
    Type: Grant
    Filed: December 15, 2013
    Date of Patent: September 7, 2021
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Aravind Seshadri, Anand Muthurajan, Jyh-Han Lin, Ke-Cheng Huang, Patrick Plaisted, Rui Liang
  • Publication number: 20210168178
    Abstract: An online meeting system begins the process of connecting a user to an online meeting when the user enters a prejoin dialog for choosing meeting settings, rather than waiting until the user chooses to actually join the meeting after entering settings. Starting the meeting connection process at this time allows a shorter perceived connection time to the meeting and thus reduces user frustration with the meeting system.
    Type: Application
    Filed: December 3, 2019
    Publication date: June 3, 2021
    Applicant: MICROSOFT TECHNOLOGY LICENSING, LLC
    Inventors: Nagaswapna BHAMIDIPATI, Xin HE, Milica JOVANOVIC, Artur Pawel KANIA, Namendra KUMAR, Rui LIANG, Yue LI, Joel Harodi MARQUEZ CATANO, Abhilash Chandrasekharan NAIR, Gaurav PANCHOLI, Jindrich PARUS, Martin PETRLA, Denis POSTU, Rama Krishan Prasad SATYA PRAKASH, Kensaku SUEDA, Balvinder Kaur THIND, Hao XU
  • Patent number: 11008313
    Abstract: The present invention relates to PCSK9 allosteric binding compounds of Formula I: (Formula (I)) and pharmaceutically acceptable salts thereof, wherein X1, X2, Y, R1, R2, RA, RB and n are as defined herein. The present invention also relates to compositions which comprise an allosteric binding compound of the invention or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. The invention further relates, inter alia, to methods for inducing PCSK9 protein degradation in a subject, and methods for treating atherosclerosis, hypercholesterolemia, coronary heart disease, metabolic syndrome, acute coronary syndrome, or related cardiovascular disease and cardiometabolic conditions, comprising administering to a subject an effective amount of a compound or a pharmaceutically acceptable salt of the invention. The invention also provides a means for the in vitro labeling, detection and/or quantification of PCSK9 in biological samples.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: May 18, 2021
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Jason Eugene Imbriglio, Whitney Lane Petrilli, Yusheng Xiong, Zhe Feng, Hyewon Youm, Wonsuk Chang, Rui Liang, Zhijian Lu, Jerry Andrew Taylor, Scott B. Hoyt
  • Patent number: 10877099
    Abstract: Disclosed are a device and a method for testing a battery equalization circuit.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: December 29, 2020
    Assignee: BEIJING ELECTRIC VEHICLE CO., LTD.
    Inventors: Qianhui Zhang, Liguo Yan, Xingquan Qin, Zhongke Yang, Huigen Yu, Donglin Cao, Rui Liang, Dangqing Li, Zhiqiang Guo
  • Publication number: 20200369657
    Abstract: The present invention relates to PCSK9 allosteric binding compounds of Formula I: (Formula (I)) and pharmaceutically acceptable salts thereof wherein X1, X2, Y, R1, R2, RA, RB and n are as defined herein. The present invention also relates to compositions which comprise an allosteric binding compound of the invention or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. The invention further relates, inter alia, to methods for inducing PCSK9 protein degradation in a subject, and methods for treating atherosclerosis, hypercholesterolemia, coronary heart disease, metabolic syndrome, acute coronary syndrome, or related cardiovascular disease and cardiometabolic conditions, comprising administering to a subject an effective amount of a compound or a pharmaceutically acceptable salt of the invention. The invention also provides a means for the in vitro labeling, detection and/or quantification of PCSK9 in biological samples.
    Type: Application
    Filed: September 15, 2017
    Publication date: November 26, 2020
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Jason Eugene Imbriglio, Whitney Lane Petrilli, Yusheng Xiong, Zhe Feng, Hyewon Youm, Wonsuk Chang, Rui Liang, Zhijian Lu, Jerry Andrew Taylor, Scott B. Hoyt
  • Patent number: 10766919
    Abstract: A class of polycyclic compounds of general formula (I), of general formula (I?), or of general formula (I?), wherein Base1, Base2, Y, Ya, Xa, Xa1, Xb, Xb1, Xc, Xc1, Xd, Xd1, R1, R1a, R2, R2a, R3, R4, R4a, R5, R6, R6a, R7, R7a, R8, and R8a are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: September 8, 2020
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michael D. Altman, Brian Andresen, Wonsuk Chang, Matthew Lloyd Childers, Jared N. Cumming, Andrew Marc Haidle, Timothy J. Henderson, James P. Jewell, Rui Liang, Jongwon Lim, Hong Liu, Min Lu, Alan B. Northrup, Ryan D. Otte, Tony Siu, Benjamin Wesley Trotter, Quang T. Truong, Shawn P. Walsh, Kake Zhao
  • Patent number: 10730849
    Abstract: Compounds of general formula (Ia), compounds of general formula (Ia?), compounds of general formula (Ib), compounds of general formula (Ib?), compounds of general formula (I), compounds of general formula (I?), and their pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, R6, R8, R9, X1, X2, and X3 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds of the disclosure.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: August 4, 2020
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michael D. Altman, Brandon D. Cash, Wonsuk Chang, Jared N. Cumming, Andrew M. Haidle, Timothy J. Henderson, James P. Jewell, Matthew A. Larsen, Rui Liang, Jongwon Lim, Min Lu, Ryan D. Otte, Tony Siu, Benjamin Wesley Trotter, Sriram Tyagarajan
  • Patent number: 10703738
    Abstract: Compounds of general formula (Ia), compounds of general formula (Ia?), compounds of general formula (Ib), compounds of general formula (Ib?), compounds of general formula (I), compounds of general formula (I?), and their pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, R6, R8, R9, X1, X2, and X3 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds of the disclosure.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: July 7, 2020
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michael D. Altman, Brandon D. Cash, Wonsuk Chang, Jared N. Cumming, Andrew M. Haidle, Timothy J. Henderson, James P. Jewell, Matthew A. Larsen, Rui Liang, Jongwon Lim, Min Lu, Ryan D. Otte, Tony Siu, Benjamin Wesley Trotter, Sriram Tyagarajan
  • Publication number: 20200189086
    Abstract: A power tool including a housing, a motor accommodated in the housing; and an output member connected to the motor via a transmission module. The transmission module is received in a substantially vacuum chamber in the housing. The vacuum chamber effectively reduces the propagation of noises generated by the transmission module to the outside of the power tool, thus improving the user experience.
    Type: Application
    Filed: September 6, 2018
    Publication date: June 18, 2020
    Inventors: Rui LIANG, Li Guo MA, Jing Feng ZHOU
  • Patent number: 10578675
    Abstract: The invention provides a method for estimating a battery capacity of an electronic device. When a current or an average current of the battery is zero, a reference capacity is inquired from a look-up table based on a voltage of the battery. When a previously remaining capacity is greater than a reference capacity, a deduction process of a self-consumable capacity is performed one or more times for a previously recorded remaining capacity to obtain a new recorded remaining capacity smaller than the reference capacity. When the current of the battery is less than zero, a deduction process of a count capacity of discharging is performed one or more times for the previously recorded remaining capacity until a power of the battery is exhausted to obtain a first offset capacity. The first offset capacity is deducted from a previously recorded full charge capacity to estimate a new full charge capacity.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: March 3, 2020
    Assignee: STL TECHNOLOGY CO., LTD.
    Inventor: Fang-Rui Liang
  • Patent number: 10568876
    Abstract: The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof. The compounds of formula (I) are inhibitors of diacylglyceride O-acyltransferase 2 (“DGAT2”) and may be useful in the treatment, prevention and suppression of diseases mediated by DGAT2. The compounds of the present invention may be useful in the treatment of hepatic steatosis, diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, cardiorenal diseases such as chronic kidney diseases and heart failure and related diseases and conditions.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: February 25, 2020
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Jason Imbriglio, Rui Liang, Clare London, Kenneth Marby, James Tata, Ming You, Yusheng Xiong
  • Publication number: 20190337917
    Abstract: Compounds of general formula (Ia), compounds of general formula (Ia?), compounds of general formula (Ib), compounds of general formula (Ib?), compounds of general formula (I), compounds of general formula (I?), and their pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, R6, R8, R9, X1, X2, and X3 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds of the disclosure.
    Type: Application
    Filed: July 16, 2019
    Publication date: November 7, 2019
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Michael D. Altman, Brandon D. Cash, Wonsuk Chang, Jared N. Cumming, Andrew M. Haidle, Timothy J. Henderson, James P. Jewell, Matthew A. Larsen, Rui Liang, Jongwon Lim, Min Lu, Ryan D. Otte, Tony Siu, Benjamin Wesley Trotter, Sriram Tyagarajan
  • Publication number: 20190337918
    Abstract: Compounds of general formula (Ia), compounds of general formula (Ia?), compounds of general formula (Ib), compounds of general formula (Ib?), compounds of general formula (I), compounds of general formula (I?), and their pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, R6, R8, R9, X1, X2, and X3 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds of the disclosure.
    Type: Application
    Filed: July 16, 2019
    Publication date: November 7, 2019
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Michael D. Altman, Brandon D. Cash, Wonsuk Chang, Jared N. Cumming, Andrew M. Haidle, Timothy J. Henderson, James P. Jewell, Matthew A. Larsen, Rui Liang, Jongwon Lim, Min Lu, Ryan D. Otte, Tony Siu, Benjamin Wesley Trotter, Sriram Tyagarajan
  • Patent number: 10414747
    Abstract: Compounds of general formula (Ia), compounds of general formula (Ia?), compounds of general formula (Ib), compounds of general formula (Ib?), compounds of general formula (I), compounds of general formula (I?), and their pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, R6, R8, R9, X1, X2, and X3 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds of the disclosure.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: September 17, 2019
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michael D. Altman, Brandon D. Cash, Wonsuk Chang, Jared N. Cumming, Andrew M. Haidle, Timothy J. Henderson, James P. Jewell, Matthew A. Larsen, Rui Liang, Jongwon Lim, Min Lu, Ryan D. Otte, Tony Siu, Benjamin Wesley Trotter, Sriram Tyagarajan
  • Publication number: 20190227127
    Abstract: The invention provides a method for estimating a battery capacity of an electronic device. When a current or an average current of the battery is zero, a reference capacity is inquired from a look-up table based on a voltage of the battery. When a previously remaining capacity is greater than a reference capacity, a deduction process of a self-consumable capacity is performed one or more times for a previously recorded remaining capacity to obtain a new recorded remaining capacity smaller than the reference capacity. When the current of the battery is less than zero, a deduction process of a count capacity of discharging is performed one or more times for the previously recorded remaining capacity until a power of the battery is exhausted to obtain a first offset capacity. The first offset capacity is deducted from a previously recorded full charge capacity to estimate a new full charge capacity.
    Type: Application
    Filed: September 28, 2018
    Publication date: July 25, 2019
    Inventor: Fang-Rui Liang